» Articles » PMID: 38081564

Enhanced Family History-based Algorithms Increase the Identification of Individuals Meeting Criteria for Genetic Testing of Hereditary Cancer Syndromes but Would Not Reduce Disparities on Their Own

Overview
Journal J Biomed Inform
Publisher Elsevier
Date 2023 Dec 11
PMID 38081564
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: This study aimed to 1) investigate algorithm enhancements for identifying patients eligible for genetic testing of hereditary cancer syndromes using family history data from electronic health records (EHRs); and 2) assess their impact on relative differences across sex, race, ethnicity, and language preference.

Materials And Methods: The study used EHR data from a tertiary academic medical center. A baseline rule-base algorithm, relying on structured family history data (structured data; SD), was enhanced using a natural language processing (NLP) component and a relaxed criteria algorithm (partial match [PM]). The identification rates and differences were analyzed considering sex, race, ethnicity, and language preference.

Results: Among 120,007 patients aged 25-60, detection rate differences were found across all groups using the SD (all P < 0.001). Both enhancements increased identification rates; NLP led to a 1.9 % increase and the relaxed criteria algorithm (PM) led to an 18.5 % increase (both P < 0.001). Combining SD with NLP and PM yielded a 20.4 % increase (P < 0.001). Similar increases were observed within subgroups. Relative differences persisted across most categories for the enhanced algorithms, with disproportionately higher identification of patients who are White, Female, non-Hispanic, and whose preferred language is English.

Conclusion: Algorithm enhancements increased identification rates for patients eligible for genetic testing of hereditary cancer syndromes, regardless of sex, race, ethnicity, and language preference. However, differences in identification rates persisted, emphasizing the need for additional strategies to reduce disparities such as addressing underlying biases in EHR family health information and selectively applying algorithm enhancements for disadvantaged populations. Systematic assessment of differences in algorithm performance across population subgroups should be incorporated into algorithm development processes.

Citing Articles

Social vulnerability and genetic service utilization among unaffected BRIDGE trial patients with inherited cancer susceptibility.

Bather J, Goodman M, Harris A, Del Fiol G, Hess R, Wetter D BMC Cancer. 2025; 25(1):180.

PMID: 39891096 PMC: 11783932. DOI: 10.1186/s12885-025-13495-4.


Identification of Individuals With Hereditary Cancer Risk Through Multiple Data Sources: A Population-Based Method Using the GARDE Platform and The Utah Population Database.

Del Fiol G, Madsen M, Bradshaw R, Newman M, Kaphingst K, Tavtigian S JCO Clin Cancer Inform. 2024; 8:e2400142.

PMID: 39571109 PMC: 11583850. DOI: 10.1200/CCI-24-00142.

References
1.
Kaphingst K, Kohlmann W, Lorenz Chambers R, Goodman M, Bradshaw R, Chan P . Comparing models of delivery for cancer genetics services among patients receiving primary care who meet criteria for genetic evaluation in two healthcare systems: BRIDGE randomized controlled trial. BMC Health Serv Res. 2021; 21(1):542. PMC: 8170651. DOI: 10.1186/s12913-021-06489-y. View

2.
Kurian A, Abrahamse P, Furgal A, Ward K, Hamilton A, Hodan R . Germline Genetic Testing After Cancer Diagnosis. JAMA. 2023; 330(1):43-51. PMC: 10242510. DOI: 10.1001/jama.2023.9526. View

3.
Owens D, Davidson K, Krist A, Barry M, Cabana M, Caughey A . Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2019; 322(7):652-665. DOI: 10.1001/jama.2019.10987. View

4.
Bradshaw R, Kawamoto K, Kaphingst K, Kohlmann W, Hess R, Flynn M . GARDE: a standards-based clinical decision support platform for identifying population health management cohorts. J Am Med Inform Assoc. 2022; 29(5):928-936. PMC: 9006693. DOI: 10.1093/jamia/ocac028. View

5.
Wisniewski H, Gorrindo T, Rauseo-Ricupero N, Hilty D, Torous J . The Role of Digital Navigators in Promoting Clinical Care and Technology Integration into Practice. Digit Biomark. 2021; 4(Suppl 1):119-135. PMC: 7768140. DOI: 10.1159/000510144. View